Continuing Education

Name: In-Depth Look at Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs
Start: 2022-10-26T00:00:00-04:00
End: 2022-10-26T23:59:59-04:00

List
Month

October 2022
FDA NanoDay Symposium 2022

October 11, 2022

Virtual Event

The FDA NanoDay Symposium 2022 will be held on 11 October 2022. The event will address drug development of products that contain nanomaterials in their formulation and how the newly
In-Depth Look at Final FDA Guidance: Bioavailability Studies Submitted in NDAs or INDs

October 26, 2022

Virtual Event

The FDA will host a meeting on 26 October 2022 to provide additional clarity to the final guidance with respect to Agency expectations for submissions containing Bioavailability information for drug

October 2022